Uveal Malignant Melanoma and Levodopa Therapy in Parkinson’s Disease
- 1 December 1982
- journal article
- case report
- Published by Elsevier in Ophthalmology
- Vol. 89 (12) , 1464-1466
- https://doi.org/10.1016/s0161-6420(82)34616-3
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Adverse Effects of Antiparkinsonian DrugsDrugs, 1981
- Melanocytic Tumors of Interest to the OphthalmologistOphthalmology, 1980
- Levodopa and MelanomaPublished by American Medical Association (AMA) ,1979
- Selective Toxicity of 6-Hydroxydopa for Melanoma CellsJournal of Investigative Dermatology, 1979
- L-Dopa methyl ester as a new antitumour agentNature, 1977
- Parkinson's disease, melanoma, and levodopaZeitschrift für Neurologie, 1977
- Levodopa and melanomaNeurology, 1974
- Long‐term appraisal of levodopa therapyNeurology, 1972